WebNov 15, 2024 · Twist Bioscience (NASDAQ:TWST) plummeted 26% in premarket trading amid a new short report from Scorpion Capital. Scorpion Capital believes that Twist (TWST) will go to zero. Twist (TWST) short interest is 11%. Twist (TWST) didn't immediately respond to Seeking Alpha email request for comment. Earlier this month Twist, Illumina … WebNov 15, 2024 · Unlike the author of the short-seller report, Twist is a public company, and is committed to communicating truthfully, creating value for all shareholders, and being …
Twist Bioscience finds itself the target of synthetic biology short ...
WebNov 15, 2024 · Shares of Twist Bioscience Corp. TWST, -1.23% plunged 18.7% in premarket trading on Tuesday after Scorpion Capital, an activist short seller, described the company … WebNov 15, 2024 · Twist believes that the short-seller report issued by Scorpion Capital is highly misleading, with many distortions and inaccuracies. Unlike the author of the short-seller … manzotti automobili castelfranco
Twist Bioscience plunges 26% after new short report from Scorpion Capital
WebNov 15, 2024 · Twist believes that the short-seller report issued by Scorpion Capital is highly misleading, with many distortions and inaccuracies. Unlike the author of the short-seller report, Twist is a public company, and is committed to communicating truthfully, creating value for all shareholders, and being good stewards of capital. WebDec 25, 2024 · On November 15, 2024, Scorpion Capital published a short report on Twist ... Following publication of the Scorpion Report, Twist’s stock price fell $7.57 per share, ... WebOnn November 15, 2024, Scorpion Capital published a lengthy report alleging that Twist is “a cash-burning inferno that is not a going concern.” Specifically, ... According to Scorpion, Twist is perpetuating its fraud through false reporting of capital expenditures and gross margins—which Scorpion claims are actually negative. manzotte